临床分型 |
|
|
|
|
危重型患者[例(%)] | 12 (92.3) | 6 (40.0) | - | 0.006 |
重型患者[例(%)] | 1 (7.7) | 9 (60.0) | - |
|
发病至就诊时间(天) | 8.62 ± 4.17 | 6.13 ± 3.02 | 1.82 | 0.080 |
发病症状[例(%)] |
|
|
|
|
发热 | 13 (100) | 14 (93.3) | - | 1.000 |
咳嗽 | 11 (84.6) | 13 (86.7) | - | 1.000 |
气促 | 11 (84.6) | 14 (93.3) | - | 0.583 |
乏力 | 3 (23.1) | 5 (33.3) | - | 0.686 |
腹泻 | 0 (0.0) | 0 (0.0) | - | - |
基础疾病[例(%)] |
|
|
|
|
高血压 | 5 (38.5) | 6 (40.0) | - | 1.000 |
冠心病 | 2 (15.4) | 1 (6.7) | - | 0.583 |
糖尿病 | 6 (46.2) | 1 (6.7) | - | 0.029 |
慢性肾衰竭 | 3 (23.1) | 0 (0.0) | - | 0.087 |
器官功能损伤[例(%)] |
|
|
|
|
肝功损害 | 8 (61.5) | 7 (46.7) | - | 0.476 |
心肌损害 | 4 (30.8) | 4 (26.7) | - | 1.000 |
休克 | 1 (7.7) | 2 (13.3) | - | 1.000 |
细胞免疫缺陷 | 13 (100) | 12 (80.0) | - | 0.226 |
病情评分 |
|
|
|
|
APACHE II评分(分) | 11.2 ± 6.7 | 11.7 ± 6.1 | −0.241 | 0.812 |
SOFA 评分(分) | 3.0 (2.0, 5.0) | 3.0 (2.0, 4.0) | −0.165 | 0.869 |
实验室检查指标 |
|
|
|
|
氧合指数(mmhg) | 222.5 ± 54.6 | 232.7 ± 61.1 | −0.462 | 0.648 |
中性粒细胞率(%) | 83.0 ± 8.0 | 75.0 ± 9.0 | 2.509 | 0.019 |
淋巴细胞计数(×109/L) | 0.70 ± 0.45 | 1.06 ± 0.47 | −2.062 | 0.049 |
C-反应蛋白(mg/L) | 52.05 ± 38.86 | 45.04 ± 43.74 | 0.445 | 0.660 |
CD3细胞计数(个/mL) | 429.38 ± 309.27 | 534.14 ± 270.70 | −0.938 | 0.357 |
CD4/CD8 (%) | 1.53 ± 1.34 | 1.68 ± 0.50 | −0.368 | 0.718 |
乳酸脱氢酶(U/L) | 333.15 ± 130.04 | 325.60 ± 100.09 | 0.174 | 0.864 |
血清铁蛋白(ng/mL) | 484.03 ± 356.05 | 376.07 ± 147.17 | 1.020 | 0.323 |
白细胞计数(×109/L) | 7.54 (4.20, 10.67) | 5.86 (4.63, 8.45) | −0.852 | 0.394 |
CD4细胞计数(个/mL) | 159.0 (86.0, 357.5) | 274.0 (165.3, 445.0) | −1.068 | 0.286 |
CD8细胞计数(个/mL) | 106.0 (78.0, 201.0) | 218.0 (88.0, 251.5) | −0.704 | 0.482 |
空腹血糖(mmol/L) | 10.75 (8.22, 13.46) | 5.76 (5.66, 7.21) | −3.478 | 0.001 |
D-二聚体(ug/ml) | 1.52 (1.08, 2.02) | 0.79 (0.59, 1.28) | −2.234 | 0.025 |
病毒转阴时间(天) | 32.0 ± 4.0 | 16.0 ± 3.0 | 11.067 | <0.001 |
糖化血红蛋白(%) | 6.02 ± 0.792 | 5.38 ± 0.843 | 1.736 | 0.385 |